In a typical year one out of every three people who die in the hospital, die from Sepsis, but new clinical trials in Milwaukee have the potential to save lives.
HHS is sending tests to large commercial labs while other labs are prepping assays as part of what some suggest is a more coordinated response than that to COVID-19.
New instruments with compact sizes and flexible pricing could help MALDI make inroads with smaller microbiology labs where it has had less of a presence to date.